158
Participants
Start Date
August 31, 2012
Primary Completion Date
May 31, 2015
Study Completion Date
June 30, 2015
4.0 mg iSONEP
4.0 mg iSONEP given monthly intravitreously for 4 months
0.5 mg iSONEP
0.5 mg iSONEP given monthly intravitreously for 4 months
0.5 mg Lucentis or 1.25 mg Avastin or 2 mg Eylea
0.5 mg Lucentis or 1.25 mg Avastin or 2 mg Eylea given monthly intravitreously for 4 months
sham injection
administered monthly for 4 months
Island Retina, Shirley
Associates in Ophthalmology, West Mifflin
Retina Group of Washington, Chevy Chase
Retina Specialists, Towson
Retina Group of Washington, Fairfax
Charlotte Eye Ear Nose & Throat Associates, Charlotte
Palmetto Retina Center, West Columbia
Retina Specialty Institute, Pensacola
Fort Lauderdale Eye Institute, Plantation
Florida Eye Microsurgical Institute, Boynton Beach
Center for Retina & Macular Disease, Winter Haven
Retina Health Center, Fort Myers
East Florida Eye Institute, Stuart
Bennett & Bloom Eye Centers, Louisville
Midwest Eye Institute, Indianapolis
Sagar Kenyon American Eye Institute, New Albany
Retina Consultants of Michigan, Southfield
Henry Ford Health System, Detroit
TLC Eye Care and Laser Center, Jackson
Central Plains Eye MDs, Wichita
Texas Retina Associates, Dallas
Medical Center Ophthalmology Associates, San Antonio
Retina Associates of South Texas, San Antonio
Valley Retina Institute, Harlingen
Austin Retina Associates, Austin
Retina Research Center, Austin
Retina Research Institute of Texas, Abilene
Rocky Mountain Retina Consultants, Salt Lake City
Retina Consultants of Arizona, Phoenix
Associated Retina Consultants, Phoenix
Retina Consultants of Arizona, Peoria
Retina Centers, P.C., Tucson
Retina-Vitreous Associates Medical Group, Beverly Hills
Specialty Eye Care Medical Center, Glendale
Retina Associates of Orange County, Laguna Hills
Orange County Retina Medical Group, Santa Ana
Miramar Eye Specialists, Ventura
Northern California Retina Vitreous Associates, Mountain View
Retinal Diagnostic Center, Campbell
Retinal Consultants Medical Group, Inc., Sacramento
Retina Consultants of Hawaii, ‘Aiea
Retina & Vitreous Center SO, Ashland
Spokane Eye Clinical Research, Spokane
Ophthalmic Consultants of Boston, Boston
Lpath, Inc.
INDUSTRY